Decrease in gastric sensitivity to distension by 5-HT1A receptor agonists in rats

Area of Science:

• Neurogastroenterology
• Pharmacology
• Pain Research

Background:

• Gastric sensitivity and compliance are crucial for digestive function.
• The role of serotonin 5-HT1A receptors in modulating gastric sensory pathways is not fully understood.
• Investigating central mechanisms of gastric sensory processing is essential for understanding visceral pain.

Purpose of the Study:

• To investigate the effect of 5-hydroxytryptamine 1A (5-HT1A) receptor agonists on gastric sensitivity and pain threshold in an in vivo rat model.
• To determine if these effects are mediated specifically through 5-HT1A receptors in the central nervous system.

Main Methods:

• Utilized an in vivo rat model with isobaric gastric distensions using a barostat.
• Administered 5-HT1A agonists (8-OH-DPAT, Flesinoxan) and antagonists (WAY 100635) via intraperitoneal and intracerebroventricular routes.
• Monitored behavioral responses and measured gastric tone and pain thresholds.

Main Results:

• The 5-HT1A agonist 8-OH-DPAT increased gastric pain threshold and gastric tone.
• Central administration of 8-OH-DPAT produced similar effects, which were blocked by the 5-HT1A antagonist WAY 100635.
• Another 5-HT1A agonist, Flesinoxan, replicated these findings, and alpha2-receptor antagonism did not alter the effects of 8-OH-DPAT.

Conclusions:

• Activation of 5-HT1A receptors within the central nervous system plays a significant role in modulating gastric sensory processing.
• Central 5-HT1A receptor activation increases gastric tone and reduces gastric sensitivity to distension.
• These findings suggest potential therapeutic targets for managing visceral pain and functional gastrointestinal disorders.